News
SMC gives Bayer's CKD therapy Kerendia the green light in Sc...
In another win for Bayer, the Scottish Medicines Consortium (SMC) has accepted the company’s chronic kidney disease (CKD) drug, Kerendia (finerenone), for the treatment of adults with CKD a
